Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
November 14, 2018
Small cell carcinoma of the upper urinary tract and factors associated with progress survival: a systematic review and pooled analysis
Ning Jiang, Dawei Tian, Zhonghua Shen, et al.
Experimental and Therapeutic Medicine
|
October 19, 2017
The expression of vasohibin-1 and its prognostic significance in bladder cancer
Bo Zhang, Zhouliang Wu, Wanqin Xie, et al.
Oncotargets and Therapy
|
February 13, 2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
Yu Zhang, Linguo Xie, Tao Chen, et al.
Medicine
|
February 5, 2016
Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study
Zhonghua Shen, Linguo Xie, Tao Chen, et al.
Oncotargets and Therapy
|
December 18, 2015
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
Linguo Xie, Yan Sun, Tao Chen, et al.
International Journal of Molecular Sciences
|
October 28, 2014
Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population
Yu Zhang, Yan Sun, Tao Chen, et al.
Molecular Immunology
|
December 2, 2022
NONO regulates multiple cytokine production in sepsis via the ERK1/2 signaling pathway
Ya Niu, Guangyu Xu, Shaoping Zhu, et al.
Urology
|
March 19, 2019
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Zhangqun Ye, Jian Huang, Liqun Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer
Yunkai Qie, Shiwang Huang, Chong Shen, et al.
Asian Journal of Urology
|
December 22, 2017
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database
Kaiwen Li, Tianxin Lin, , et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
November 14, 2018
Small cell carcinoma of the upper urinary tract and factors associated with progress survival: a systematic review and pooled analysis
Ning Jiang, Dawei Tian, Zhonghua Shen, et al.
Experimental and Therapeutic Medicine
|
October 19, 2017
The expression of vasohibin-1 and its prognostic significance in bladder cancer
Bo Zhang, Zhouliang Wu, Wanqin Xie, et al.
Oncotargets and Therapy
|
February 13, 2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
Yu Zhang, Linguo Xie, Tao Chen, et al.
Medicine
|
February 5, 2016
Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study
Zhonghua Shen, Linguo Xie, Tao Chen, et al.
Oncotargets and Therapy
|
December 18, 2015
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
Linguo Xie, Yan Sun, Tao Chen, et al.
International Journal of Molecular Sciences
|
October 28, 2014
Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population
Yu Zhang, Yan Sun, Tao Chen, et al.
Molecular Immunology
|
December 2, 2022
NONO regulates multiple cytokine production in sepsis via the ERK1/2 signaling pathway
Ya Niu, Guangyu Xu, Shaoping Zhu, et al.
Urology
|
March 19, 2019
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Zhangqun Ye, Jian Huang, Liqun Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer
Yunkai Qie, Shiwang Huang, Chong Shen, et al.
Asian Journal of Urology
|
December 22, 2017
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database
Kaiwen Li, Tianxin Lin, , et al.
Page
of 4